CDKN2A and neoplasm: These functional alterations were associated with changes in the expression of different tumour markers (CCND1, CDKN2A, etc.; determined by qPCR), which were modulated in a cell‐dependent manner in response of EIF4A3‐silencing (Figure 3F).